Role of Mosapride in Patients With Gastroesophageal Reflux Disease

Summary

Gastroesophageal reflux disease (GERD) is a very common disease in the Western World. In Taiwan, this disease is increasing gradually because the investigators' eating style is closing to Western world. Proton pump is the main drug for patients with GERD in the past two decades. Prokinetic agent is an important adjuvant to the therapy of GERD. This study aims to evaluate the role of prokinetic agent in the management of GERD.

Timeline

Start

2008-06

Primary completion

2009-04

Completion

2009-05

Drugs

Indications